Antioxidative and anti-inflammatory effects of monoterpene linalool in rats with letrozole-induced polycystic ovarian syndrome: modulation of autophagy and apoptosis
Abstract
Polycystic ovarian syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting women of reproductive age, frequently associated with infertility, metabolic complications, and chronic inflammation mediated by NF-κB activation. This is the first study to examine the effects of linalool (Lin), an acyclic monoterpene, on PCOS-related complications in rats. Adult female rats were randomly assigned to six experimental groups (n = 6): control, Lin 100, PCOS, PCOS + Lin 50, PCOS + Lin 100, and PCOS + Metformin (Met). To induce PCOS, letrozole (1 mg/kg) was administered orally to the rats for 21 days. After PCOS induction, the rats were orally treated with Lin (50 and 100 mg/kg) and Met (300 mg/kg) for 14 days. Linalool remarkably mitigated ovarian histopathological alterations and fibrosis and significantly improved fasting blood glucose levels and insulin sensitivity in PCOS rats. Hormonal disturbances in PCOS rats, including elevated LH and testosterone levels, decreased FSH levels, and increased LH/FSH ratio, were considerably ameliorated after Lin treatment. Additionally, Lin treatment markedly decreased oxidative stress and inflammatory responses in PCOS rats, as demonstrated by enhanced glutathione peroxidase activity and decreased malondialdehyde, NF-κB p65, and TNF-α levels. Linalool partially restored impaired autophagy in PCOS rats by upregulating LC3-I and LC3-II. Conversely, Lin administration significantly inhibited excessive ovarian apoptosis in PCOS rats…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.